ARTICLE ABSTRACT
Making raw data from clinical trials widely publically available should reduce selective reporting biases and enhance the reproducibility of and trust in clinical research. The optimal procedures for data sharing are hotly debated. Some of the caveats and limitations in proposed data-sharing policies are potentially restrictive, and we argue in favor of more widespread availability of data from clinical research.
Link to access full article: https://www.ncbi.nlm.nih.gov/pubmed/24295825
Please Sign in (or Register) to view further.